Neonc Technologies Holdings (NTHI) Other Working Capital Changes (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Other Working Capital Changes of -$15760.0 for Q1 2026, down 162.88% quarter-over-quarter from $25062.0 in Q4 2025.
Neonc Technologies Holdings (NTHI) Other Working Capital Changes (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Other Working Capital Changes for 3 consecutive years, with -$15760.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$15760.0; the TTM figure through Mar 2026 stood at -$87846.0 (changed N/A YoY), while the FY2025 annual figure was -$12167.0, up 95.03% from the prior year.
- Other Working Capital Changes slipped to -$15760.0 in Q1 2026 per NTHI's latest filing, from $25062.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $25062.0 in Q4 2025 and bottomed at -$80377.0 in Q4 2024.
- Historically, Other Working Capital Changes has averaged -$29782.6 across 3 years, with a median of -$16771.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 131.18% in 2025 and fell as far as 72.54% in 2025.
- Neonc Technologies Holdings' Other Working Capital Changes stood at -$80377.0 in 2024, then soared by 131.18% to $25062.0 in 2025, then tumbled by 162.88% to -$15760.0 in 2026.
- Business Quant data shows NTHI's Other Working Capital Changes at -$15760.0 in Q1 2026, $25062.0 in Q4 2025, and -$16771.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17,836.00 |
| Jun 30, 2026 | -17,836.00 |
| Jun 30, 2026 | -17,836.00 |
| Mar 31, 2026 | -15,760.00 |
| Mar 31, 2026 | -15,760.00 |
| Mar 31, 2026 | -15,760.00 |
| Dec 31, 2025 | 25,062.00 |
| Dec 31, 2025 | 25,062.00 |
| Dec 31, 2025 | 25,062.00 |
| Sep 30, 2025 | -16,771.00 |
| Sep 30, 2025 | -16,771.00 |
| Sep 30, 2025 | -16,771.00 |
| Dec 31, 2024 | -80,377.00 |
| Dec 31, 2024 | -80,377.00 |
| Dec 31, 2024 | -80,377.00 |
| Sep 30, 2024 | -61,067.00 |
| Sep 30, 2024 | -61,067.00 |
| Sep 30, 2024 | -61,067.00 |